Convatec Group (CTEC)

Sector:

Health Care

Index:

FTSE 100

205.20p
   
  • Change Today:
    -3.80p
  • 52 Week High: 209.40
  • 52 Week Low: 203.60
  • Currency: UK Pounds
  • Shares Issued: 2,049.79m
  • Volume: 6,705,737
  • Market Cap: £4,206.17m
  • RiskGrade: 96
  • Beta: 0.00

CTEC Overview

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Its products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Based in Reading, it employs over 9,000 people in more than 100 countries.
Competitors: Consort Medical

Key Personnel

Chairman: John McAdam
CEO: Jonny Mason
CFO: Fiona Ryder
Independent Non-Executive Director: Brian May
Independent Non-Executive Director: Heather Mason
Independent Non-Executive Director: Kimberly Lody
Independent Non-Executive Director: Sharon O'Keefe
Senior Independent Non-Executive Director: Margaret Ewing
Non-Executive Dir:

Contact Details

Address: 7th Floor, 20 Eastbourne Terrace, London, United Kingdom, W2 6LG
Phone: +44 (0) 118 952 8100
Website: http://www.convatecgroup.com

Listings

Sector: Health Care(LSE)
Index: FTSE 100, FTSE 350, FTSE All-Share
ISIN: GB00BD3VFW73

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CTEC Market Data

Currency UK Pounds
Share Price 205.20p
Change Today -3.80p
% Change -1.82 %
52 Week High 209.40
52 Week Low 203.60
Volume 6,705,737
Shares Issued 2,049.79m
Market Cap £4,206.17m
Beta 0.00
RiskGrade 96

CTEC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.22% below the market average94.22% below the market average94.22% below the market average94.22% below the market average94.22% below the market average
15.15% below the sector average15.15% below the sector average15.15% below the sector average15.15% below the sector average15.15% below the sector average
Price Trend
26.97% above the market average26.97% above the market average26.97% above the market average26.97% above the market average26.97% above the market average
65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average
Income
69.27% below the market average69.27% below the market average69.27% below the market average69.27% below the market average69.27% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Growth
52.30% above the market average52.30% above the market average52.30% above the market average52.30% above the market average52.30% above the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average

What The Brokers Say

Strong Buy 8
Buy 7
Neutral 2
Sell 0
Strong Sell 0
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CTEC Dividends

  Latest Previous
  Final Interim
Ex-Div 16-Apr-26 21-Aug-25
Paid 28-May-26 01-Oct-25
Amount 5.37¢ 1.88¢

Trades for 08-May-2026

Time Volume / Share Price
17:13 1,475,000 @ 206.02p
16:49 9,709 @ 205.20p
16:37 100,000 @ 205.20p
16:35 5,414 @ 205.20p
16:35 32,705 @ 205.20p

CTEC Key Personnel

Chair John McAdam
CEO Jonny Mason
CFO Fiona Ryder

Top of Page